ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.496,79
0,12%
S&P 500
5.235,48
-0,60%
Dow Jones
38.111,48
-0,86%
Euro vs US Dollar
1,0818
-0,12%
Bitcoin
68.527,02
0,24%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Midatech Pharma PLC (MTP)

  7. Midatech Pharma PLC (MTP) News

MTP

Midatech Pharma (MTP)

Midatech Pharma PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MTP
DatumZeitQuelleÜberschriftSymbolFirma
29/05/202415h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
29/05/202415h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
29/05/202415h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
29/05/202415h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
29/05/202415h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
28/05/202423h03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
22/05/202422h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
22/05/202422h04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
22/05/202416h21Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
22/05/202416h16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
22/05/202416h14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
22/05/202416h10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
22/05/202415h23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
21/05/202416h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
15/05/202422h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
15/05/202412h46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
03/05/202422h09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
03/05/202422h09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
03/05/202422h09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
03/05/202422h09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
03/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTPMidatech Pharma PLC
03/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTPMidatech Pharma PLC
03/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTPMidatech Pharma PLC
03/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTPMidatech Pharma PLC
30/04/202419h11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
30/04/202403h55Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MTPMidatech Pharma PLC
30/04/202403h49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MTPMidatech Pharma PLC
30/04/202403h47Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MTPMidatech Pharma PLC
26/04/202414h45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
19/04/202414h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:MTP

Kürzlich von Ihnen besucht

TG
SS91
Smith Micro Software
TG
DW51
Aemetis
TG
CP6
Cooper Companies
NASDAQ
FHYCUX
Dividend and Income Port...
LSE
46BJ
Perm Mast A2 42
ASX
MEJNA
ASX
BBAB
BetaShares Capital
USOTC
GVFGU
Gerova Financial (GM)
COIN
HPOOUSD
Hippocrat
ASX
SOL
Washington H Soul Pattin...
AMEX
NWI
Nuveen Maryland Fund
BOV
BIDU34
Baidu
NASDAQ
AAXYNXX
Bank of Montreal Capped ...
NYSE
ALL.PRG
Allstate Corp. (The)
NYSE
ETP.PRC
Sunoco Logistics Partners L.P.
TG
DRH
DroneShield
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten